〇Kazuya Tsurudome¹, Masako Tanabe², Taku Izumi¹, Hironori Ohshiro¹, Yoshimi Katayama² (1.Sophion Bioscience K.K., 2.Medicinal Research Dept., Biological Research Lab., Nissan Chemical Corp.)

〇Kouichi Hashimoto¹, Yosuke Yamawaki^2,1, Kenji Yamaoka¹, Takayuki Yoshida¹, Kana Okada¹, Wanqin Tan¹, Miwako Yamasaki³, Yoshiko Matsumoto-Makidono¹, Reika Kubo¹, Hisako Nakayama^6,1, Tsutomu Kataoka¹, Takashi Kanematsu^4,1, Masahiko Watanabe³, Yasumasa Okamoto¹, Shigeru Morinobu^5,1, Hidenori Aizawa¹, Shigeto Yamawaki¹ (1.Grad Sch BioMed Health Sci, Hiroshima Univ, Hiroshima, Japan, 2.Daiichi Univ Pharmacy, Fukuoka, Japan, 3.Sch Medicine, Hokkaido Univ, Sapporo, Japan, 4.Dent Sci, Kyushu Univ, Fukuoka, Japan, 5.Grad Psychol, Kibi international Univ, Okayama, Japan, 6.Sch Med, Tokyo Women's Med Univ, Tokyo, Japan)